Abstract:Normalizing the tumor vasculature has been proposed as a therapeutic paradigm. However, to function normally, microvessels must exist as a vasoreactive and hierarchical network with red blood cells flowing single file through capillaries. Such a network has not been identified in malignant tumors. We previously found that fibroblast growth factor 9 (FGF9) could stabilize new blood vessels in ischemic muscle. To determine if FGF9 impacted tumors vessels, renal carcinoma (Renca) cells, expressing GFP or FGF9, were implanted into the subcapsular space of female Balb/c mice. After 14 days, the resulting FGF9-tumors had 17% fewer microvessels than control tumors (p=0.003) but the vessels had a collagen-fortified basement membrane and were more extensively covered with pericytes (4-fold, p=0.015) and smooth muscle cells (14-fold, p=0.002). Notably, this was associated with reduced pulmonary metastases (p=0.029). Intravital video microscopy revealed that FGF9 converted a haphazard web of channels into a hierarchal network with arterioles, capillaries, and venules. There was also a 33% reduction in vessel length density (p=0.034), a 67% reduction in mean lumen diameter (pu003c0.001), and 57% fewer bifurcations (p=0.019). Moreover, whereas vasoreactivity was absent in control tumors, arterioles in FGF9-tumors could constrict and dilate in response to adrenergic and nitric oxide releasing agents, respectively. Pimonidazole infusion revealed a 33% reduction of hypoxia in the tumor core (p=0.031) with a 35% reduction in VEGFA expression (p=0.031). Immunostaining and selective cell harvesting revealed that FGF9 selectively amplified a population of PDGFRs-positive stromal cells in the tumor (p=0.045). Furthermore, in vivo blocking of PDGFRs prevented microvascular differentiation by FGF9 and worsened metastases (p=0.002).Conclusion: FGF9 can impart an otherwise dysfunctional tumor microvasculature with hierarchy, vasoreactivity, and improved oxygen delivery, via selective amplification of PDGFRs-expressing mesenchymal stromal cells. These findings suggest an approach to driving microvascular network differentiation, to an extent not observed previously, to pacify the tumor.

Endothelial miR-30c suppresses tumor growth via inhibition of TGF-&bgr;–induced Serpine1

SUMOylated NICD in Endothelial Cell Suppresses Tumor Angiogenesis

Abstract 23: Microrna302-367 Sphingosine 1 Phosphate Receptor 1 Pathway Prevents Tumor Growth Via Restricting Angiogenesis and Enhancing Vascular Stability

A MicroRNA302-367-Erk1/2-Klf2-S1pr1 Pathway Prevents Tumor Growth via Restricting Angiogenesis and Improving Vascular Stability.

Elevated Expression of Mir302-367 in Endothelial Cells Inhibits Developmental Angiogenesis Via CDC42/CCND1 Mediated Signaling Pathways

Heparin-binding EGF-like growth factor via miR-126 controls tumor formation/growth and the proteolytic niche in murine models of colorectal and colitis-associated cancers

Abstract 431: Conversion of Tumor Microvessels into a Hierarchical and Vasoreactive Network, and Suppression of Metastases, by Fibroblast Growth Factor 9

Extracellular Domain of TGFβ Type III Receptor Inhibits Angiogenesis and Tumor Growth in Human Cancer Cells

Human Fibulin-3 Protein Variant Expresses Anti-Cancer Effects in the Malignant Glioma Extracellular Compartment in Intracranial Xenograft Models

Endothelial epsin deficiency decreases tumor growth by enhancing VEGF signaling.

Identification of Tumor-Suppressive miR-30e-3p Targets: Involvement of SERPINE1 in the Molecular Pathogenesis of Head and Neck Squamous Cell Carcinoma

HIF1α Counteracts TGFβ1-Driven TSP1 Expression in Endothelial Cells to Stimulate Angiogenesis in the Hypoxic Tumor Microenvironment

MiR-148b-3p Inhibits Renal Carcinoma Cell Growth and Pro-Angiogenic Phenotype of Endothelial Cell Potentially by Modulating FGF2.

Tumor Cell-Secreted Angiogenin Induces Angiogenic Activity of Endothelial Cells by Suppressing Mir-542-3p

Mir-301A Suppression Within Fibroblasts Limits the Progression of Fibrosis Through the TSC1/mTOR Pathway

Global Microrna Depletion Suppresses Tumor Angiogenesis.

The Mir-30 Family Inhibits Pulmonary Vascular Hyperpermeability in the Premetastatic Phase by Direct Targeting of Skp2.

Csf1r mediates enhancement of intestinal tumorigenesis caused by inactivation of Mir34a

Mir-139 And Mir-200c Regulate Pancreatic Cancer Endothelial Cell Migration And Angiogenesis

miR-30d-5p inhibits proliferation, invasion and migration of breast cancer cells by targeting SERPINE1 and promoting fatty acid β-oxidation

Mir526b and Mir655 Promote Tumour Associated Angiogenesis and Lymphangiogenesis in Breast Cancer